Zhiyi Biotechnology
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Biologics company focused on biosimilar development and manufacturing, with ambitions in novel antibodies.
OncologyImmunology
Technology Platform
Advanced mammalian cell culture and bioprocessing platform for the development and production of biosimilar and novel antibodies.
Opportunities
Capitalizing on China's biosimilar adoption wave and potentially transitioning to a higher-margin innovative biologics portfolio.
Risk Factors
Intense price competition in biosimilars and significant capital requirements for manufacturing scale-up.
Competitive Landscape
Competes in the crowded but strategic Chinese biosimilars market, where cost, speed to market, and manufacturing quality are key differentiators.